2022 -2024 Senior Director Clinical Development, Innovative Medicines, Immunology TA, Teva Pharmacuticals @
2020 -2022 Clinical Lead Type 1 diabetes Programs, World Without Disease Accelerator, Janssen Pharmaceuticals @
2018 -2020 Vice President, Clinical Development @ Provention Bio
2014 -2018 Director, Immunology Early Development and Translational Medicine @
2009 -2015 Protocol Chair and Network Steering Committee @
2011 -2014 Academic Chief Pediatric Critical Care and Scientist in the Wells Center for Diabetes Research @
2003 -2011 Faculty - Pediatric Critical Care and Transplant Immunolgy at the Emory Transplant Center @
Mark Rigby Education
The Johns Hopkins University School of Medicine
(Pediatric Critical Care - Fellowship)
2000-2003
The Johns Hopkins University School of Medicine
(Pediatrics - Internship and Residency)
1997-2000
UMass Chan Medical School
Doctor of Medicine (MD) (Medicine)
1991-1997
UMass Chan Medical School
Doctor of Philosophy (PhD) (Immunology/Type 1 diabetes)
1991-1997
Duke University
Bachelor of Science (BS) (Zoology/Animal Biology)
1987-1991
Mark Rigby Summary
Mark Rigby, based in Philadelphia, PA, US, is currently a Executive Director, Clinical Development, AnaptysBio at AnaptysBio. Mark Rigby brings experience from previous roles at Teva Pharmaceuticals, The Janssen Pharmaceutical Companies of Johnson & Johnson and Provention Bio. Mark Rigby holds a 2000 - 2003 The Johns Hopkins University School of Medicine. Mark Rigby has 1 emails and 1 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.